From European to National guidelines on heart disease

被引:8
作者
Grip, Lars [1 ]
Lindahl, Bertil [2 ]
Levin, Lars-Ake [3 ]
Karvinge, Christina [4 ]
Eklund, Kristina [4 ]
Wallentin, Lars [2 ]
机构
[1] Univ Gothenburg, Inst Med, Gothenburg, Sweden
[2] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
[3] Linkoping Univ, Ctr Med Technol Assessment, Linkoping, Sweden
[4] Natl Board Hlth & Welf, Stockholm, Sweden
关键词
Guidelines; national; Sweden; heart disease; recommendations; prioritizations; MANAGEMENT; FAILURE;
D O I
10.3109/14017431.2010.536566
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aims. Guidelines from the European Society of Cardiology are important tools for defining and establishing current standards of care for various heart diseases. The aim of the present paper is to describe the process of how these international guidelines may be transformed and implemented at a national level in Sweden. Methods/results. The structure and process behind the national guidelines for heart diseases in Sweden and their relationship to the underlying European guidelines are described and differences between the national and European levels highlighted. We also give examples of how the scientific values of health care measures are weighted against health economic perspectives and integrated in a prioritization process. Compared to the European guidelines, the Swedish national guidelines have a broader economic perspective and aim to ensure that health care is cost effective and provided to all Swedish citizens on equal terms. Discussion. When certain health care measures are implemented, the national process can result in other priorities than could be expected from the European guidelines alone. On the other hand, a forceful implementation may be facilitated by the societal context in which these national guidelines are produced.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 19 条
[1]  
Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
[2]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[3]   Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation Two Systematic Literature Reviews and Meta-Analyses [J].
Calkins, Hugh ;
Reynolds, Matthew R. ;
Spector, Peter ;
Sondhi, Manu ;
Xu, Yingxin ;
Martin, Amber ;
Williams, Catherine J. ;
Sledge, Isabella .
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (04) :349-U49
[4]  
Camm A J., 2010, Eur Heart J
[5]  
CARLSSON P, 2003, LAKARTIDNINGEN, V100, P2446
[6]  
Carlsson P, 2006, LAKARTIDNINGEN, V103, P3622
[7]  
CARLSSON P, 2007, NATL MODELL OPPNA VE, V1
[8]  
Carlsson Per, 2006, Lakartidningen, V103, P3617
[9]  
Dickstein K, 2010, EUR HEART J, V2010
[10]  
Eliasson Mats, 2003, Lakartidningen, V100, P20